Veracyte, Inc. · Healthcare · Healthcare
As of 2026-06-26, Veracyte, Inc. (VCYT) has a 3-month relative strength percentile of 95 and a leadership percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.0%, relative volume 2.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 95, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
VCYT is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 40.3% / 54.9%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VCYT is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.17% weight, $153M notional. Top 3 carry $297M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.17% | $153M |
| VTIVanguard Total Stock Market ETF | 0.00% | $81M |
| XBIState Street SPDR S&P Biotech ETF | 0.85% | $63M |
| IWMiShares Russell 2000 ETF | 0.09% | $62M |
| VBVanguard Small Cap ETF | 0.04% | $59M |
| VBKVanguard Small-Cap Growth ETF | 0.09% | $33M |
| VXFVanguard Extended Market ETF | 0.03% | $28M |
| IWOiShares Russell 2000 Growth ETF | 0.17% | $21M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VCYT Jan avg: 0.54% median: -1.58% win: 50% σ: 11.93% n: 4 2022-04-12 → 2026-05-29 | VCYT Feb avg: -8.86% median: -4.89% win: 0% σ: 9.93% n: 4 2022-04-12 → 2026-05-29 | VCYT Mar avg: -10.49% median: -10.68% win: 0% σ: 3.75% n: 4 2022-04-12 → 2026-05-29 | VCYT Apr avg: -4.85% median: 1.52% win: 60% σ: 10.02% n: 5 2022-04-12 → 2026-05-29 | VCYT May avg: 6.85% median: 6.03% win: 60% σ: 22.53% n: 5 2022-04-12 → 2026-05-29 | VCYT Jun avg: 4.41% median: 3.01% win: 75% σ: 6.35% n: 4 2022-04-12 → 2026-05-29 (current) | VCYT Jul avg: 9.47% median: 9.26% win: 75% σ: 18.57% n: 4 2022-04-12 → 2026-05-29 | VCYT Aug avg: 8.53% median: 12.61% win: 50% σ: 26.24% n: 4 2022-04-12 → 2026-05-29 | VCYT Sep avg: -3.25% median: -3.76% win: 50% σ: 16.10% n: 4 2022-04-12 → 2026-05-29 | VCYT Oct avg: 4.54% median: 2.11% win: 50% σ: 12.16% n: 4 2022-04-12 → 2026-05-29 | VCYT Nov avg: 30.00% median: 29.25% win: 100% σ: 6.15% n: 4 2022-04-12 → 2026-05-29 | VCYT Dec avg: -6.47% median: -9.43% win: 25% σ: 9.67% n: 4 2022-04-12 → 2026-05-29 |